Literature DB >> 24778110

Origins of a 350-kilobase genomic duplication in Mycobacterium tuberculosis and its impact on virulence.

Pilar Domenech1, Anya Rog1, Jalal-ud-din Moolji1, Nicolas Radomski1, Ashley Fallow1, Lizbel Leon-Solis1, Julia Bowes1, Marcel A Behr2, Michael B Reed3.   

Abstract

In the present study, we have investigated the evolution and impact on virulence of a 350-kb genomic duplication present in the most recently evolved members of the Mycobacterium tuberculosis East Asian lineage. In a mouse model of infection, comparing HN878 subclones HN878-27 (no duplication) and HN878-45 (with the 350-kb duplication) revealed that the latter is impaired for in vivo growth during the initial 3 weeks of infection. Furthermore, the median survival time of mice infected with isolate HN878-45 is significantly longer (77 days) than that of mice infected with HN878-27. Whole-genome sequencing of both isolates failed to reveal any mutational events other than the duplication that could account for such a substantial difference in virulence. Although we and others had previously speculated that the 350-kb duplication arose in response to some form of host-applied selective pressure (P. Domenech, G. S. Kolly, L. Leon-Solis, A. Fallow, M. B. Reed, J. Bacteriol. 192: 4562-4570, 2010, and B. Weiner, J. Gomez, T. C. Victor, R. M. Warren, A. Sloutsky, B. B. Plikaytis, J. E. Posey, P. D. van Helden, N. C. Gey van Pittius, M. Koehrsen, P. Sisk, C. Stolte, J. White, S. Gagneux, B. Birren, D. Hung, M. Murray, J. Galagan, PLoS One 7: e26038, 2012), here we show that this large chromosomal amplification event is very rapidly selected within standard in vitro broth cultures in a range of isolates. Indeed, subclones harboring the duplication were detectable after just five rounds of in vitro passage. In contrast, the duplication appears to be highly unstable in vivo and is negatively selected during the later stages of infection in mice. We believe that the rapid in vitro evolution of M. tuberculosis is an underappreciated aspect of its biology that is often ignored, despite the fact that it has the potential to confound the data and conclusions arising from comparative studies of isolates at both the genotypic and phenotypic levels.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24778110      PMCID: PMC4097636          DOI: 10.1128/IAI.01791-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  60 in total

1.  Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta.

Authors:  C Manca; L Tsenova; A Bergtold; S Freeman; M Tovey; J M Musser; C E Barry; V H Freedman; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

2.  Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti.

Authors:  Alexander S Pym; Priscille Brodin; Roland Brosch; Michel Huerre; Stewart T Cole
Journal:  Mol Microbiol       Date:  2002-11       Impact factor: 3.501

3.  Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin.

Authors:  D R Sherman; M Voskuil; D Schnappinger; R Liao; M I Harrell; G K Schoolnik
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

4.  Genome plasticity in Acinetobacter: new degradative capabilities acquired by the spontaneous amplification of large chromosomal segments.

Authors:  Andrew B Reams; Ellen L Neidle
Journal:  Mol Microbiol       Date:  2003-03       Impact factor: 3.501

5.  Genetic diversity in Mycobacterium tuberculosis.

Authors:  Sebastien Gagneux
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

6.  A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosis.

Authors:  Gyanu Lamichhane; Matteo Zignol; Natalie J Blades; Deborah E Geiman; Annette Dougherty; Jacques Grosset; Karl W Broman; William R Bishai
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-29       Impact factor: 11.205

7.  A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes.

Authors:  B López; D Aguilar; H Orozco; M Burger; C Espitia; V Ritacco; L Barrera; K Kremer; R Hernandez-Pando; K Huygen; D van Soolingen
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

8.  Genes required for mycobacterial growth defined by high density mutagenesis.

Authors:  Christopher M Sassetti; Dana H Boyd; Eric J Rubin
Journal:  Mol Microbiol       Date:  2003-04       Impact factor: 3.501

9.  Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation.

Authors:  Kaeryn N Lewis; Reiling Liao; Kristi M Guinn; Mark J Hickey; Sherilyn Smith; Marcel A Behr; David R Sherman
Journal:  J Infect Dis       Date:  2002-12-02       Impact factor: 5.226

10.  Use of whole genome sequencing to determine the microevolution of Mycobacterium tuberculosis during an outbreak.

Authors:  Midori Kato-Maeda; Christine Ho; Ben Passarelli; Niaz Banaei; Jennifer Grinsdale; Laura Flores; Jillian Anderson; Megan Murray; Graham Rose; L Masae Kawamura; Nader Pourmand; Muhammad A Tariq; Sebastien Gagneux; Philip C Hopewell
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more
  12 in total

1.  Validation of Novel Mycobacterium tuberculosis Isoniazid Resistance Mutations Not Detectable by Common Molecular Tests.

Authors:  Justin L Kandler; Alexandra D Mercante; Tracy L Dalton; Matthew N Ezewudo; Lauren S Cowan; Scott P Burns; Beverly Metchock; Peter Cegielski; James E Posey
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

2.  Respiratory flexibility in response to inhibition of cytochrome C oxidase in Mycobacterium tuberculosis.

Authors:  Kriti Arora; Bernardo Ochoa-Montaño; Patricia S Tsang; Tom L Blundell; Stephanie S Dawes; Valerie Mizrahi; Tracy Bayliss; Claire J Mackenzie; Laura A T Cleghorn; Peter C Ray; Paul G Wyatt; Eugene Uh; Jinwoo Lee; Clifton E Barry; Helena I Boshoff
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

3.  Unique Regulation of the DosR Regulon in the Beijing Lineage of Mycobacterium tuberculosis.

Authors:  Pilar Domenech; Jason Zou; Alexandra Averback; Nishath Syed; Daniele Curtis; Samuel Donato; Michael B Reed
Journal:  J Bacteriol       Date:  2016-12-28       Impact factor: 3.490

4.  Rapid adaptation of a complex trait during experimental evolution of Mycobacterium tuberculosis.

Authors:  Tracy M Smith; Madison A Youngblom; John F Kernien; Mohamed A Mohamed; Sydney S Fry; Lindsey L Bohr; Tatum D Mortimer; Mary B O'Neill; Caitlin S Pepperell
Journal:  Elife       Date:  2022-06-21       Impact factor: 8.713

5.  Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosis.

Authors:  Yumi Park; Angela Pacitto; Tracy Bayliss; Laura A T Cleghorn; Zhe Wang; Travis Hartman; Kriti Arora; Thomas R Ioerger; Jim Sacchettini; Menico Rizzi; Stefano Donini; Tom L Blundell; David B Ascher; Kyu Rhee; Ardala Breda; Nian Zhou; Veronique Dartois; Surendranadha Reddy Jonnala; Laura E Via; Valerie Mizrahi; Ola Epemolu; Laste Stojanovski; Fred Simeons; Maria Osuna-Cabello; Lucy Ellis; Claire J MacKenzie; Alasdair R C Smith; Susan H Davis; Dinakaran Murugesan; Kirsteen I Buchanan; Penelope A Turner; Margaret Huggett; Fabio Zuccotto; Maria Jose Rebollo-Lopez; Maria Jose Lafuente-Monasterio; Olalla Sanz; Gracia Santos Diaz; Joël Lelièvre; Lluis Ballell; Carolyn Selenski; Matthew Axtman; Sonja Ghidelli-Disse; Hannah Pflaumer; Markus Bösche; Gerard Drewes; Gail M Freiberg; Matthew D Kurnick; Myron Srikumaran; Dale J Kempf; Simon R Green; Peter C Ray; Kevin Read; Paul Wyatt; Clifton E Barry; Helena I Boshoff
Journal:  ACS Infect Dis       Date:  2016-10-17       Impact factor: 5.084

6.  TnSeq of Mycobacterium tuberculosis clinical isolates reveals strain-specific antibiotic liabilities.

Authors:  Allison F Carey; Jeremy M Rock; Inna V Krieger; Michael R Chase; Marta Fernandez-Suarez; Sebastien Gagneux; James C Sacchettini; Thomas R Ioerger; Sarah M Fortune
Journal:  PLoS Pathog       Date:  2018-03-05       Impact factor: 6.823

7.  Utilisation of the Prestwick Chemical Library to identify drugs that inhibit the growth of mycobacteria.

Authors:  Panchali Kanvatirth; Rose E Jeeves; Joanna Bacon; Gurdyal S Besra; Luke J Alderwick
Journal:  PLoS One       Date:  2019-03-12       Impact factor: 3.240

8.  Reference set of Mycobacterium tuberculosis clinical strains: A tool for research and product development.

Authors:  Sònia Borrell; Andrej Trauner; Daniela Brites; Leen Rigouts; Chloe Loiseau; Mireia Coscolla; Stefan Niemann; Bouke De Jong; Dorothy Yeboah-Manu; Midori Kato-Maeda; Julia Feldmann; Miriam Reinhard; Christian Beisel; Sebastien Gagneux
Journal:  PLoS One       Date:  2019-03-25       Impact factor: 3.240

9.  The SNAP hypothesis: Chromosomal rearrangements could emerge from positive Selection during Niche Adaptation.

Authors:  Gerrit Brandis; Diarmaid Hughes
Journal:  PLoS Genet       Date:  2020-03-04       Impact factor: 5.917

Review 10.  Immunological consequences of strain variation within the Mycobacterium tuberculosis complex.

Authors:  Leopold D Tientcheu; Anastasia Koch; Mthawelenga Ndengane; Genevieve Andoseh; Beate Kampmann; Robert J Wilkinson
Journal:  Eur J Immunol       Date:  2017-02-24       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.